Pregnancy and Childbirth
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Multiparous pregnant women aged 18-40 years, with singleton pregnancy in cephalic presentation, admitted in active phase (at cervical dilatation of 4 to 6 cm) of spontaneous labour at term (37 weeks – 41 weeks + 6 days gestation) whose rate of cervical dilatation is less than 1 cm per hour as assessed four hours into admission
Exclusion criteria
Exclusion criteria: Grand multiparity Multiple pregnancy Previous uterine scar Cervical dilation = 7 cm at admission Cervical cerclage Chronic or pregnancy induced medical conditions Presence of any contraindication to vaginal delivery Allergy to hyoscine-n-butyl bromide History suggestive of, or previous diagnoses of glaucoma, myasthenia gravis, obstructive uropathy, asthma, cardiac, liver or renal disease, seizure disorder or psychiatric illness Prolonged Prelabour rupture of the fetal membranes (rupture of fetal membrane with latency period greater than 24hrs) Congenital fetal malformations Intra uterine growth restriction (IUGR) Cephalopelvic disproportion Intrauterine fetal death (IUFD) Non consenting patient
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.To determine the effect of intravenous hyoscine-n-butyl bromide on the duration of active phase of labour (from the point of intervention) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.To determine the effect of intravenous hyoscine-n-butyl bromide on the rate of cervical dilatation (from the point of intervention) ;2.To determine the incidence of the side effects of intravenous hyoscine-n-butyl bromide in the first stage of labour ;3.To determine the neonatal Apgar score at 1 and 5 minutes | — |
Countries
Nigeria
Contacts
Consultant Obstetrician and Gynaecologist